In this video, Paolo F. Caimi, MD, MBA, discusses research evaluating whether multi-virus specific T-cells could enhance ...

Of these, 10 had anti-AQP4 antibody-positive NMOSD, 5 had anti-MOG antibody-positive NMOSD, and 30 were double seronegative. The patients’ median best corrected visual acuity was 1.7 at onset. The ...

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its ...

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® Published. Jun 5, 2025 11:45am EDT.

DFA: Direct fluorescent antibody; VZV: Varicella zoster virus. References. Authors and Disclosures. ... The clinical significance of positive molecular results may vary in the individual patient.

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its ...

Positive results for modified version. In the June 2025 issue of The Lancet HIV, a team of researchers reported the results of an open-label phase 1 trial of PGDM1400LS that was the first to test the ...

The second dose of MMRV elicited slight to moderate increases in measles, mumps and rubella antibody titers and a substantial increase in varicella antibody titer (from 13.0 to 588.1 glycoprotein ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab ... negative breast cancer that tests positive for the immune checkpoint PD-L1.

The panic button was pressed throughout the Windy City on Sunday afternoon when the Chicago Cubs pulled their superstar right fielder Kyle Tucker out of the game.. For the first time in his Cubs ...

The Lancet Oncology, Elena Elimova and colleagues present the results of a multicentre phase 2 trial, 5 conducted in patients with HER2-positive advanced gastrooesophageal adenocarcinoma using a novel ...

Of the 261 pregnant patients with ANAs positivity, 70.99% (185/261) were positive for ANA and 29.11% (76/261) were negative for ANA but positive for other antibodies in the spectrum of ANA. The ...